1 recruiting, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Radiofrequency Ablation: new trials by email Literature Review of Radiofrequency Ablation trials Research Report on Radiofrequency Ablation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RFA Plus Carrizumab vs Carrizumab Alone for HCC radiofrequency ablation - Tumor Immunity, Immunosuppression | Phase 2 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 120 | 2020-08-01 | 2020-07-08 |
| RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial Neo-MASCT - Primary Liver Cancer, Radiofrequency Ablation | Phase 2 | Unknown | Sun Yat-sen University | 98 | 2017-07-25 | 2022-01-26 |
Adenocarcinoma (2) · Carcinoma (2) · Digestive System Diseases (2) · Digestive System Neoplasms (2) · Liver Diseases (2) · Liver Neoplasms (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Glandular and Epithelial (2)
Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · Sun Yat-sen University (1)
China (2)
Ming Kuang, Ph.D. (1) · Zhe Tang, Dr. (1)